Nvlax 75 SR Tablet contains Pregabalin 75mg, an anticonvulsant and neuropathic pain agent used primarily for the management of neuropathic pain, partial onset seizures, and generalized anxiety disorder. Pregabalin acts by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby modulating neurotransmitter release and reducing neuronal excitability. Nvlax 75 SR is formulated as a sustained-release tablet to provide a consistent plasma concentration, enhancing patient compliance and therapeutic efficacy. It is indicated for the treatment of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury, as well as adjunctive therapy for partial seizures in adults. Additionally, it is utilized in the management of generalized anxiety disorder. Common adverse effects may include dizziness, somnolence, dry mouth, and peripheral edema, which are generally mild to moderate and tend to diminish with continued use. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Nvlax 75 SR should be used under medical supervision, with gradual dose titration to minimize side effects. It is contraindicated in patients with known hypersensitivity to pregabalin or any of its excipients.